Kestra Medical Technologies, LTD 10-Q quarterly reports

Kestra Medical Technologies announced significant revenue and gross profit increases in its latest quarterly report, driven by patient growth, while also reporting continued net losses and ongoing efforts to address internal control weaknesses.

Kestra Medical Technologies, Ltd. reported a 53% revenue increase for the quarter ended October 31, 2025, driven by patient growth, but also saw a significant rise in net loss and identified material weaknesses in internal controls.

Kestra Medical Technologies, Ltd. announced a 52% revenue increase to $19.4 million for Q1 2026, driven by patient growth, despite a 27% rise in net loss to $25.8 million and identified material weaknesses in internal controls.

Kestra Medical Technologies reports a significant increase in revenue for the quarter ended January 31, 2025, but also discloses material weaknesses in its internal control over financial reporting.